Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease

被引:260
|
作者
Caputi, Valentina [1 ,2 ]
Giron, Maria Cecilia [1 ]
机构
[1] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Pharmacol Bldg, I-35131 Padua, Italy
[2] Univ Coll Cork, APC Microbiome Ireland, Cork T12 YT20, Ireland
来源
关键词
enteric microbiota; brain-gut axis; Parkinson's disease; toll-like receptors; innate immunity; central nervous system; enteric nervous system; gastrointestinal dysfunctions; probiotics; pharmacological treatment; -synuclein; gut dysbiosis; neurons; microglia; glial cells; intestinal barrier permeability; CERULEIN-INDUCED PANCREATITIS; INTERNATIONAL SCIENTIFIC ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; ALPHA-SYNUCLEIN; NERVOUS-SYSTEM; SENSORY NERVES; DOCOSAHEXAENOIC ACID; INNATE IMMUNITY; FATTY-ACIDS; INTESTINAL INFLAMMATION;
D O I
10.3390/ijms19061689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a progressively debilitating neurodegenerative disease characterized by -synucleinopathy, which involves all districts of the brain-gut axis, including the central, autonomic and enteric nervous systems. The highly bidirectional communication between the brain and the gut is markedly influenced by the microbiome through integrated immunological, neuroendocrine and neurological processes. The gut microbiota and its relevant metabolites interact with the host via a series of biochemical and functional inputs, thereby affecting host homeostasis and health. Indeed, a dysregulated microbiota-gut-brain axis in PD might lie at the basis of gastrointestinal dysfunctions which predominantly emerge many years prior to the diagnosis, corroborating the theory that the pathological process is spread from the gut to the brain. Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs primarily found in microorganisms and a dysregulation in their signaling may be implicated in -synucleinopathy, such as PD. An overstimulation of the innate immune system due to gut dysbiosis and/or small intestinal bacterial overgrowth, together with higher intestinal barrier permeability, may provoke local and systemic inflammation as well as enteric neuroglial activation, ultimately triggering the development of alpha-synuclein pathology. In this review, we provide the current knowledge regarding the relationship between the microbiota-gut-brain axis and TLRs in PD. A better understanding of the dialogue sustained by the microbiota-gut-brain axis and innate immunity via TLR signaling should bring interesting insights in the pathophysiology of PD and provide novel dietary and/or therapeutic measures aimed at shaping the gut microbiota composition, improving the intestinal epithelial barrier function and balancing the innate immune response in PD patients, in order to influence the early phases of the following neurodegenerative cascade.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Microbiome-gut-brain axis crosstalk and clinical outcomes
    Zhang, Xiaojie
    FRONTIERS IN NUTRITION, 2024, 11
  • [22] The Microbiome-Gut-Brain Axis and Dementia: A Bibliometric Analysis
    Sun, He-Li
    Feng, Yuan
    Zhang, Qinge
    Li, Jia-Xin
    Wang, Yue-Ying
    Su, Zhaohui
    Cheung, Teris
    Jackson, Todd
    Sha, Sha
    Xiang, Yu-Tao
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (24)
  • [23] Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies
    Kouli, Antonina
    Horne, C. B.
    Williams-Gray, C. H.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 41 - 51
  • [24] Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
    Paul J Kennedy
    John F Cryan
    Timothy G Dinan
    Gerard Clarke
    World Journal of Gastroenterology, 2014, 20 (39) : 14105 - 14125
  • [25] Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis
    Gheorghe, Cassandra Elise
    Martin, Jason A.
    Manriquez, Francisca Villalobos
    Dinan, Timothy G.
    Cryan, John F.
    Clarke, Gerard
    CURRENT OPINION IN PHARMACOLOGY, 2019, 48 : 137 - 145
  • [26] The microbiome-gut-brain axis as a regulator of serotonergic neurotransmission and behaviour
    Clarke, G.
    Grenham, S.
    Scully, P.
    Fitzgerald, P.
    Moloney, R.
    Shanahan, F.
    Dinan, T.
    Cryan, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 149 - 149
  • [27] Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
    Kennedy, Paul J.
    Cryan, John F.
    Dinan, Timothy G.
    Clarke, Gerard
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (39) : 14105 - 14125
  • [28] Advances in Understanding the Regulation of Obesity by Microbiome-Gut-Brain Axis
    Wang Y.
    Liu X.
    Shipin Kexue/Food Science, 2021, 42 (11): : 313 - 323
  • [29] Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease
    Yang, Ying
    Stewart, Tessandra
    Zhang, Can
    Wang, Pan
    Xu, Zhi
    Jin, Jinghua
    Huang, Yang
    Liu, Zongran
    Lan, Guoyu
    Liang, Xingguang
    Sheng, Lifu
    Shi, Min
    Cai, Zhijian
    Zhang, Jing
    MOVEMENT DISORDERS, 2024, 39 (01) : 40 - 52
  • [30] Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases
    Ghaisas, Shivani
    Maher, Joshua
    Kanthasamy, Anumantha
    PHARMACOLOGY & THERAPEUTICS, 2016, 158 : 52 - 62